Joining Cadre of Next-Gen Arrayer Shops, Wasatch Microfluidics Plans for Q3 Debut

The two-year-old company’s technology will initially target antibody engineers and protein-array users, groups that others in the space say are driving the demand for new arrayers to replace existing ones, some of which are a decade old.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.